Stefano Nobile

Dr. Stefano Nobile

Fondazione Policlinico Universiario "A. Gemelli" IRCCS, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Pediatrics
Verified
Journal Article
Closed access
PDF file
FRFrancesco Raimondi
Francesco Raimondi
FMFiorella Migliaro
Fiorella Migliaro
ICIuri Corsini
Iuri Corsini
FMFabio Meneghin
Fabio Meneghin
PDPasquale Dolce
Pasquale Dolce
GLGianluca Lista
Gianluca Lista
BACKGROUND AND OBJECTIVES: The utility of a lung ultrasound score (LUS) has been described in the early phases of neonatal respiratory distress syndrome (RDS). We investigated lung ultrasound as a tool to monitor respiratory status in preterm neonates throughout the course of RDS. METHODS: Preterm neonates, stratified in 3 gestational age cohorts (25–27, 28–30, and 31–33 weeks), underwent lung ultrasound at weekly intervals from birth. Clinical data, respiratory support variables, and major complications (sepsis, patent ductus arteriosus, pneumothorax, and persistent pulmonary hypertension of the neonate) were also recorded. RESULTS: We enrolled 240 infants in total. The 3 gestational age intervals had significantly different LUS patterns. There was a significant correlation between LUS and the ratio of oxygen saturation to inspired oxygen throughout the admission, increasing with gestational age (b = −0.002 [P < .001] at 25–27 weeks; b = −0.006 [P < .001] at 28–30 weeks; b = −0.012 [P < .001] at 31–33 weeks). Infants with complications had a higher LUS already at birth (12 interquartile range 13–8 vs 8 interquartile range 12–4 control group; P = .001). In infants 25 to 30 weeks’ gestation, the LUS at 7 days of life predicted bronchopulmonary dysplasia with an area under the curve of 0.82 (95% confidence interval 0.71 to 93). CONCLUSIONS: In preterm neonates affected by RDS, the LUS trajectory is gestational age dependent, significantly correlates with the oxygenation status, and predicts bronchopulmonary dysplasia. In this population, LUS is a useful, bedside, noninvasive tool to monitor the respiratory status.

1 December 2021 in Chest
Verified
Journal Article
Closed access
FRFrancesco Raimondi
Francesco Raimondi
FMFiorella Migliaro
Fiorella Migliaro
ICIuri Corsini
Iuri Corsini
FMFabio Meneghin
Fabio Meneghin
Luca PierriLuca Pierri
Luca Pierri
GLGianluca Lista
Gianluca Lista

6 May 2023 in World Journal of Clinical Cases
Verified
Journal Article
Open access
MDMartina D'Agostin
Martina D'Agostin
CMChiara Di Sipio Morgia
Chiara Di Sipio Morgia
GVGiovanni Vento
Giovanni Vento
Stefano NobileStefano Nobile
Stefano Nobile
Fetal growth restriction (FGR), or intrauterine growth restriction (IUGR), is a complication of pregnancy where the fetus does not achieve its genetic growth potential. FGR is characterized by a pathological retardation of intrauterine growth velocity in the curve of intrauterine growth. However, the FGR definition is still debated, and there is a lack of a uniform definition in the literature. True IUGR, compared to constitutional smallness, is a pathological condition in which the placenta fails to deliver an adequate supply of oxygen and nutrients to the developing fetus. Infants with IUGR, compared to appropriately grown ges tational age infants, have a significantly higher risk of mortality and neonatal complications with long-term consequences. Several studies have demonstrated how suboptimal fetal growth leads to long-lasting physiological alterations for the developing fetus as well as for the newborn and adult in the future. The long-term effects of fetal growth retardation may be adaptations to poor oxygen and nutrient supply that are effective in the fetal period but deleterious in the long term through structural or functional alterations. Epidemiologic studies showed that FGR could be a contributing factor for adult chronic diseases including cardiovascular disease, metabolic syndrome, diabetes, respiratory diseases and impaired lung function, and chronic kidney disease. In this review we discussed pathophysiologic mechanisms of FGR-related complications and potential preventive measures for FGR.

Verified
Journal Article
Open access
PDF file
Stefano NobileStefano Nobile
Stefano Nobile
CMChiara Di Sipio Morgia
Chiara Di Sipio Morgia
GVGiovanni Vento
Giovanni Vento
The “developmental origins of health and disease” (DOHaD) hypothesis refers to the influence of early developmental exposures and fetal growth on the risk of chronic diseases in later periods. During fetal and early postnatal life, cell differentiation and tissue formation are influenced by several factors. The interaction between genes and environment in prenatal and early postnatal periods appears to be critical for the onset of multiple diseases in adulthood. Important factors influencing this interaction include genetic predisposition, regulation of gene expression, and changes in microbiota. Premature birth and intrauterine growth restriction (IUGR) are other important factors considered by the DOHaD hypothesis. Preterm birth is associated with impaired or arrested structural or functional development of key organs/systems, making preterm infants vulnerable to cardiovascular, respiratory, and chronic renal diseases during adulthood. Growth restriction, defined as impaired fetal growth compared to expected biological potential in utero, is an additional negative factor increasing the risk of subsequent diseases. Environmental factors implicated in the developmental programming of diseases include exposure to pollution, stress, drugs, toxic agents, nutrition, and exercise. The DOHaD may explain numerous conditions, including cardiovascular, metabolic, respiratory, neuropsychiatric, and renal diseases. Potential antenatal and postnatal preventive measures, interventions, and future directions are discussed.

1 February 2021 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
GVGiovanni Vento
Giovanni Vento
MVMaria Luisa Ventura
Maria Luisa Ventura
RPRoberta Pastorino
Roberta Pastorino
AKAnton H van Kaam
Anton H van Kaam
VCVirgilio Carnielli
Virgilio Carnielli
JPJ Jane Pillow
J Jane Pillow

28 June 2017 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
Stefano NobileStefano Nobile
Stefano Nobile
PMPaolo Marchionni
Paolo Marchionni
VCVirgilio P Carnielli
Virgilio P Carnielli